FOLH1 and prostate carcinoma: Prostate-specific membrane antigen (PSMA) is a transmembrane protein which is significantly overexpressed in prostate carcinoma cells, and its expression increases with tumor aggressiveness [4, 5, 13, 20, 21], metastatic disease and recurrence while normal prostatic tissue expresses PSMA sparsely [22–24].